US Platform to Measure Influenza Vaccine Effectiveness against Laboratory-confirmed Influenza-associated

Funding Opportunity Number: RFA-IP-15-002 Opportunity Category: DiscretionaryFunding Instrument Type: Cooperative AgreementCategory of Funding Activity: HealthCFDA Number: 93.185Eligible Applicants Others (see text field entitled "Additional Information on Eligibility" for clarification)Agency Name: HHS-CDC-HHSCDCERAClosing Date: Mar 03, 2015Award Ceiling: $300,000Expected Number of Awards: 4Creation Date: Jan 13, 2015Funding Opportunity Description: The goal of this funding announcement is to establish a sustainable network of US institutions that can obtain hospitalization data and provide accurate estimates of annual influenza vaccine effectiveness (VE) to prevent influenza-associated hospitalizations in US adult populations. Participating institutions will coordinate enrollment of adult hospitalized patients with acute respiratory illness (ARI), confirm influenza infection using sensitive laboratory-based molecular assays, and estimate VE using a test-negative study design.
Source: Grants.gov - Category: Research Tags: Health Source Type: funding